WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Stock-Based Compensation
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Stock-Based Compensation of $2.55 million for the 9-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $774.92K, a 78.78% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $5.87M, a 4516.33% increase year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. share-based payment arrangement, noncash expense for the quarter ending 2011-06-30 was $3.09M.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. share-based payment arrangement, noncash expense for fiscal 2011 was $10.03M, a 160.97% increase from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. share-based payment arrangement, noncash expense for fiscal 2010 was $3.84M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11 | $2.55M 10-Q/A · filed 2012-12-11 | ||
| 2012-06-30 | $2.55M 10-Q/A · filed 2012-08-30 | |||
| 2011-12-31 | $774.92K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $6.65M derived: sum of 2 quarters · filed 2012-12-11 | $9.74M derived: sum of 3 quarters · filed 2012-12-11 | $10.03M 10-K · filed 2012-03-30 |
| 2011-09-30 | $5.87M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11 | $8.96M derived: sum of 2 quarters · filed 2012-12-11 | $9.26M 10-Q/A · filed 2012-12-11 | $12.91M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-06-30 | $3.09M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | $3.38M 10-Q/A · filed 2012-08-30 | $7.04M derived: sum of 3 quarters · filed 2012-08-30 | $7.16M derived: sum of 4 quarters · filed 2012-08-30 |
| 2011-03-31 | $292.25K 10-Q · filed 2012-05-15 | $3.94M derived: sum of 2 quarters · filed 2012-05-15 | $4.07M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $3.78M derived: sum of 2 quarters · filed 2012-03-30 | $3.84M 10-K · filed 2012-03-30 | |
| 2010-09-30 | $127.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $192.40K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $65.20K 10-Q/A · filed 2011-09-01 |